CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis [version 3; peer review: 2 approved, 1 approved with reservations]
Background In-stent restenosis (ISR) remains a major drawback in coronary stenting. The association between the CYP2C19 loss of function (LOF) gene and the prevalence of ISR after coronary stenting remains controversial. Previous studies have produced conflicting results and have been limited by the...
Saved in:
Main Authors: | Ivana Purnama Dewi, Irawan Yusuf, Agussalim Bukhari, Muzakkir Amir, Vitriyaturrida ., Yusra Pintaningrum, Idar Mappangara, Hendy Bhaskara Perdana Putra |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2025-01-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/11-346/v3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYP2C19 Genotype‐Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure
by: Kayla R. Tunehag, et al.
Published: (2025-01-01) -
Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01) -
Anti-inflammatory coupled anti-angiogenic airway stent effectively suppresses tracheal in-stents restenosis
by: Yanan Zhao, et al.
Published: (2025-01-01) -
Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01) -
定点突变法确定人体CYP2A6 和 CYP2A13香豆素 代谢的关键氨基酸
Published: (2009-01-01)